BioNTech SE (BNTX)
NASDAQ • Healthcare
January 21, 2026 at 21:00 UTC
BioNTech SE is a biotechnology company that turns insights in immunology into therapies designed for serious diseases. The model links research platforms with clinical programs and manufacturing methods that can be scaled when evidence supports them. Work spans mRNA and other modalities, but the operating tone stays consistent: design carefully, test with rigor, and communicate results so physicians and regulators can act with confidence. Partnerships extend reach without changing that core rhythm. The goal is to move promising ideas into treatments that fit the routines of modern medicine, with supply and guidance that are as clear as the science behind them.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
BioNTech SE's Technical Indicators Summary
BNTX is exhibiting a strong bullish trend, supported by an ADX reading near 28 that indicates solid trend strength. Momentum remains robust, with the MACD and CCI signaling upward movement, even as some oscillators like RSI and MFI suggest overbought conditions. The current price trading well above all major moving averages, including the 200-day SMA and EMA, reinforces the positive price action. Volatility appears steady, with the ATR reflecting moderate daily price swings. Meanwhile, volume-based indicators like OBV confirm buying interest despite a significant negative value. Overall, these factors combine to affirm a sustained bullish technical outlook for BNTX.
| Indicator | Value |
|---|---|
RSI (14) | 70.65 |
Stochastic %K (14, 3, 3) | 88.28 |
CCI (20) | 167.77 |
WPR (14) | -13.09 |
Momentum (10) | 12.31 |
MFI | 89.10 |
MACD Level (12, 26) | 2.71 |
Bollinger Bands | $87.38 - $109.57 |
ATR (14) | $2.86 (2.63%) |
ADX (14) | 27.81 |
OBV | -11,026,900 |
Exponential Moving Averages | $99.80 - $103.63(5 indicators) |
Simple Moving Averages | $98.47 - $102.93(5 indicators) |
Get premium market insights delivered directly to your inbox.
BNTX saw only a marginal positive bias at the bell, opening 0.038% above 105.56 at 105.60. The first stretch of the session shows barely any flow, with BNTX at 0.21× normal volume. BNTX's limited early trading activity suggests subdued investor interest amid no recent company-specific news.
Price Change
from $105.56 close
+$4.29
Trading Volume
Below avg (1.0M)
215.7K
vs S&P 500 Today
Strong Outperformance
+3.43%
52-Week Position
Mid-range
62.9%
Updated: January 21, 2026 at 15:36 UTC